After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Harmony Biosciences Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Harmony Biosciences Holdings Inc is $1.99B. A total of 0.83 million shares were traded on the day, compared to an average of 634.35K shares.
In the most recent transaction, Dierks Jeffrey sold 4,869 shares of HRMY for 32.67 per share on Mar 03 ’25. After the transaction, the CHIEF COMMERCIAL OFFICER now owns 0 company shares. In a previous transaction on Mar 03 ’25, JEFFREY G DIERKS bought 4,869 shares at 33.85 per share.
Among the insiders who sold shares, Dierks Jeffrey disposed of 13,125 shares on Jan 24 ’25 at a per-share price of $37.31. This resulted in the CHIEF COMMERCIAL OFFICER holding 0 shares of HRMY after the transaction. In another insider transaction, Dierks Jeffrey sold 1,629 shares at $38.02 per share on Jan 27 ’25. Company shares held by the CHIEF COMMERCIAL OFFICER now total 0.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HRMY has a high of $41.61 and a low of $28.14.
As of this writing, HRMY has an earnings estimate of $1.09 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $1.45 per share and a lower estimate of $0.77.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HRMY’s latest balance sheet shows that the firm has $234.31M in Cash & Short Term Investments as of fiscal 2021. There were $191.98M in debt and $53.77M in liabilities at the time. Its Book Value Per Share was $11.53, while its Total Shareholder’s Equity was $186.51M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HRMY is Buy with a score of 4.20.
